JSL Health Capital is a Washington DC-based investment firm and venture studio focused on funding, partnering, and building transformational healthcare companies that take advantage of data, AI, and software. Founded in 2022, the firm operates at the intersection of healthcare, artificial intelligence, and data science.

JSL Health Capital invests in late seed and growth-stage healthcare companies and positions itself as a hands-on partner that accelerates companies through commercial acceleration, technology strategy, and implementation support. The firm draws on former founders and operators who provide high-urgency, build-alongside support to portfolio companies.

Its primary focus is the United States healthcare market. JSL Health Capital is most relevant for neurotech companies with strong digital, AI, or software components that are at a late seed or growth stage and seeking operational as well as financial support.